Ruud Dobber

President, BioPharmaceuticals Business Unit at AstraZeneca LP

Ruud Dobber

Ruud Dobber

President, BioPharmaceuticals Business Unit at AstraZeneca LP

Biography

Ruud Dobber is Executive VP-Biopharmaceuticals Business at AstraZeneca Plc. In his past career he occupied the position of Chairman-Asia division at Pharmaceutical Research & Manufacturers of America. He received a doctorate from the University of Leiden.

Overview
RelSci Relationships

886

Number of Boards

1

Relationships
RelSci Relationships are individuals Ruud Dobber likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Interim Chief Executive Officer at Alexion Pharmaceuticals, Inc.

Relationship likelihood: Strong

Executive Director at AstraZeneca LP

Relationship likelihood: Strong

Executive Vice President, Human Resources & General Counsel at AstraZeneca Plc

Relationship likelihood: Strong

Chief Compliance Officer at AstraZeneca Plc

Relationship likelihood: Strong

Executive Director-Corporate Development at AstraZeneca Plc

Relationship likelihood: Strong

Chief Financial Officer & Executive Director at AstraZeneca Plc

Relationship likelihood: Strong

Executive Director, Chief Executive Officer at AstraZeneca Plc

Relationship likelihood: Strong

Executive Vice President, Oncology Business Unit at AstraZeneca Plc

Relationship likelihood: Strong

Vice President & Head of Genome Analytics & BioInformatics-Center for Genomics Research, Discovery Sciences & R&D at AstraZeneca Plc

Relationship likelihood: Strong

Chief Executive Officer, Innovation Center China at AstraZeneca Plc

Relationship likelihood: Strong

Paths to Ruud Dobber
Potential Connections via
Relationship Science
You
Ruud Dobber
President, BioPharmaceuticals Business Unit at AstraZeneca LP
Education
PhD in Immunology

Leiden University (Dutch: Universiteit Leiden), located in the city of Leiden, is the oldest university in the Netherlands.[4] The university was founded in 1575 by William, Prince of Orange, leader of the Dutch Revolt in the Eighty Years' War. The Dutch Royal Family and Leiden University still have a close relationship; Queens Juliana and Beatrix and King Willem-Alexander are all former students. Leiden University has six faculties, over 50 departments and enjoys an outstanding international reputation. In 2013 Leiden was the highest ranked university in the Netherlands in the Times Higher Education World University Rankings, where it was rated as the 64th best university worldwide and 61st for international reputation. Shanghai Jiao Tong University's 2011 Academic Ranking of World Universities ranked Leiden University as the 65th best university worldwide.[5] The Times Higher Education World University Rankings consistently rank Leiden University as the best university in Continental Europe for Arts and Humanities. The University is associated with ten leaders and Prime Ministers of the Netherlands including the current Prime Minister Mark Rutte, nine foreign leaders, among them the 6th President of the United States John Quincy Adams, two Secretary Generals of NATO, a President of the International Court of Justice and sixteen recipients of the Nobel Prize (including renowned physicists Albert Einstein and Enrico Fermi). The university came into particular prominence during the Dutch Golden Age, when scholars from around Europe were attracted to the Dutch Republic due to its climate of intellectual tolerance and Leiden's international reputation. During this time Leiden was home to such figures as René Descartes, Rembrandt, Hugo Grotius, Baruch Spinoza and Baron d'Holbach. The university is a member of the Coimbra Group, the Europaeum and the League of European Research Universities. Albert Einstein was known as a professor at Leiden University. Einstein regularly taught Leiden students for a few weeks per year. His first lecture at Leiden was about "Ether and Relativity Theory".[6] Leiden University houses more than 40 national and international research institutes.

Career History
President, BioPharmaceuticals Business Unit
Current

AstraZeneca LP, part of AstraZeneca Plc, is a company headquartered in Wilmington, DE, specializing in pharmaceutical preparations.The company says this about itself: AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular & Metabolic Diseases and Respiratory. The Company also is selectively active in the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

Executive Vice President, BioPharmaceuticals Business Unit
1997 - Current

AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Chairman-Asia Division
2011

Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC.

Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Ruud Dobber. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Ruud Dobber's profile does not indicate a business or promotional relationship of any kind between RelSci and Ruud Dobber.